About Akari Therapeutics Plc (AKTX) data
Data as of September 30, 2026.
Akari Therapeutics Plc (AKTX) has 14.53K shares sold short as of the latest FINRA settlement report on September 30, 2026. Short interest has increased by 34.99% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 0.23 days (days to cover).
Frequently asked questions
What is the current short interest in AKTX?
As of the latest FINRA settlement dated September 30, 2026, AKTX had approximately 14,529 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short AKTX?
The latest borrow fee (cost to borrow) for AKTX is 100.80% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for AKTX?
Days to cover for AKTX is approximately 0.23 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
Is AKTX a short squeeze candidate?
A squeeze needs shorts that are hard to close. AKTX trades about 62,368 shares a day and would take roughly 0.23 days to unwind current short positions, at a current borrow fee of 100.80%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.